Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?

A Tausig1, P Knesewitsch, K Brinkbäumer

  • 1Department of Nuclear Medicine, University of Munich, Germany. tausig@lrz.uni-muenchen.de

Nuclear Medicine Communications
|December 29, 2000
PubMed
Summary

A low-dose, one-day protocol using technetium-99m-sestamibi (Tc-99m-MIBI) effectively assesses myocardial perfusion and function. This method is suitable for most patients, including the obese, when adequate radiopharmaceutical doses are administered.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulsed contact glow discharge electrification for online material quantification.

Talanta·2025
Same author

Diagnosing the origin and impact of low-mode asymmetries in ignition experiments at the National Ignition Facility.

Physical review. E·2023
Same author

Reliability of a novel point of care device for monitoring diabetic peripheral neuropathy.

Scientific reports·2023
Same author

[DDB2-associated incidence of squamous cell carcinoma in Haflingers: risk minimization by genotyping].

Schweizer Archiv fur Tierheilkunde·2023
Same author

Construction and study of instrument response functions for analysis of the National Ignition Facility (NIF) neutron time-of-flight detectors.

The Review of scientific instruments·2022
Same author

A combined MeV-neutron and x-ray source for the National Ignition Facility.

The Review of scientific instruments·2022

Area of Science:

  • Nuclear Medicine
  • Cardiology
  • Radiopharmacology

Background:

  • Technetium-99m-labeled radiopharmaceuticals, such as Tc-99m-sestamibi (Tc-99m-MIBI), enable simultaneous measurement of myocardial perfusion and function.
  • Evaluating a low-dose, one-day protocol for Tc-99m-MIBI imaging is crucial for efficient patient management.

Purpose of the Study:

  • To assess the feasibility of performing first-pass radionuclide ventriculography (FP-RNV) followed by myocardial perfusion single-photon emission computed tomography (SPECT) using a low-dose Tc-99m-MIBI 1-day protocol.
  • To determine if this protocol yields adequate count statistics for functional analysis in a predominantly obese patient population.

Main Methods:

  • A consecutive cohort of 270 patients (61% obese) underwent FP-RNV before Tc-99m-MIBI SPECT.
  • Patients received stress doses of 4 MBq/kg (>300 MBq) and rest doses of 9 MBq/kg (>650 MBq).

Related Experiment Videos

  • Adequate count statistics for FP-RNV were defined by specific criteria for end-diastolic left ventricular region of interest counts.

    • Main Results:

    • 95% of stress FP-RNV studies and 100% of rest FP-RNV studies achieved adequate count statistics.
    • The 14 patients with insufficient statistics were all obese and received less than the planned radiopharmaceutical dose.
    • No significant difference in administered dose was observed among bicycle ergometry, dobutamine, or dipyridamole stress modalities.

    Conclusions:

    • A low-dose, one-day Tc-99m-MIBI protocol is suitable for assessing FP-RNV prior to SPECT in the majority of patients.
    • Administering a minimum of 300 MBq and 4 MBq/kg is recommended for technically adequate results, even in obese individuals.